Univest
Univest
  • Markets

  • Sudeep Pharma Shares Surge 75% Since IPO Price, but ICICI Securities Sets Target Below CMP: What Should Shareholders Do?

    • October 14, 2026
    • Posted by: Ankit Jaiswal
    • Category: News
    No Comments
    Sudeep Pharma Shares Surge 75% Since IPO Price, but ICICI Securities Sets Target Below CMP: What Should Shareholders Do?

    Sudeep Pharma shares are about 71% to 75% above the issue price, but ICICI Securities keeps Hold with a Rs 1,000 target. See valuation, Q1 results and risks.

    read more